X4 Pharmaceuticals Company Insiders

X4 Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.5861) % which means that it has lost $0.5861 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.2175 %, meaning that it created $1.2175 on every $100 dollars invested by stockholders. X4 Pharmaceuticals' management efficiency ratios could be used to measure how well X4 Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/28/2025, Return On Tangible Assets is likely to drop to -0.33. In addition to that, Return On Capital Employed is likely to drop to -0.34. At this time, X4 Pharmaceuticals' Net Tangible Assets are relatively stable compared to the past year. As of 07/28/2025, Debt To Assets is likely to grow to 0.56, while Total Assets are likely to drop slightly above 108.3 M. As of 07/28/2025, Common Stock Shares Outstanding is likely to grow to about 211.1 M, though Net Loss is likely to grow to (82.4 M).

X4 Pharmaceuticals Workforce Comparison

X4 Pharmaceuticals Profit Margins

The company has Profit Margin (PM) of 0.47 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.33.

X4 Pharmaceuticals Insider Trading

X4 Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as X4 Pharmaceuticals often depends on how effective the management is. X4 Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of XFOR management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the XFOR management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.